SCHEMBL22149955

SCHEMBL22149955

C=CC(=O)NCCCC(=O)Nc1ccc(CN=[N+]=[N-])nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HDAC8 Q9BY41 12/20 0.38
▸ HDAC3 O15379 7/20 0.38
▸ NCOR2 Q9Y618 3/20 0.38
▸ HDAC2 Q92769 7/20 0.36
▸ HDAC1 Q13547 6/20 0.36
▸ HDAC4 P56524 5/20 0.36
▸ HDAC7 Q8WUI4 5/20 0.36
▸ HDAC10 Q969S8 5/20 0.36
▸ HDAC11 Q96DB2 5/20 0.36
▸ HDAC6 Q9UBN7 5/20 0.36
▸ HDAC9 Q9UKV0 5/20 0.36
▸ HDAC5 Q9UQL6 5/20 0.36
▸ BLK P51451 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22150196 0.97 HDAC8 (0.39) SMN1; SMN2HDAC8HDAC3NCOR2HDAC2
SCHEMBL22149736 0.96 HDAC8 (0.40) SMN1; SMN2HDAC8HDAC3NCOR2HDAC2
SCHEMBL22122705 0.87 SMN1; SMN2 (0.41) SMN1; SMN2HDAC8HDAC3NCOR2HDAC2
SCHEMBL22149741 0.83 EGFR (0.38) HDAC8HDAC3NCOR2KDM4EMEN1
SCHEMBL23810139 0.82 SMN1; SMN2 (0.42) SMN1; SMN2HDAC8HDAC3HDAC2HDAC1
SCHEMBL22122715 0.81 SMN1; SMN2 (0.43) SMN1; SMN2HDAC8HDAC3NCOR2HDAC2
SCHEMBL30921556 0.81 CA1 (0.53) SMN1; SMN2HDAC8HDAC3NCOR2HDAC2
SCHEMBL23810206 0.80 KDM4E (0.41) HDAC8HDAC3HDAC2HDAC1HDAC6
SCHEMBL22150190 0.79 SMN1; SMN2 (0.41) SMN1; SMN2HDAC8HDAC3NCOR2HDAC2
SCHEMBL22150881 0.79 GAA (0.37) SMN1; SMN2HDAC8HDAC3NCOR2HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240300896-A1 HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS ILLUMINA CAMBRIDGE LIMITED (GB) 2024-09-12 — — US disclosed
US-11999696-B2 Heterocyclic azide units and their use in polymer coatings ILLUMINA CAMBRIDGE LIMITED (GB) 2024-06-04 — — US disclosed
CN-112672996-B Heterocyclic azide units and their use in polymeric coatings 伊鲁米纳剑桥有限公司 2024-01-05 — — CN disclosed
US-20210284609-A1 HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS ILLUMINA CAMBRIDGE LIMITED (GB) 2021-09-16 — — US disclosed
US-20210284609-A1 HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS ILLUMINA CAMBRIDGE LIMITED (GB) 2021-09-16 — — US disclosed
WO-2020126598-A1 HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS ILLUMINA CAMBRIDGE LIMITED (GB) 2020-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300896-A1 HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS POLL, PCNA, DNMT3A SMN1; SMN2 1789/4885HDAC8 1617/4885HDAC3 3176/4885
US-20210284609-A1 HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS POLL, PCNA, DNMT3A SMN1; SMN2 1789/4885HDAC8 1617/4885HDAC3 3176/4885
US-11999696-B2 Heterocyclic azide units and their use in polymer coatings POLL, PCNA, DNMT3A SMN1; SMN2 1789/4885HDAC8 1617/4885HDAC3 3176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback